Preparation and Characterization of Fe₃O₄@MTX Magnetic Nanoparticles for Thermochemotherapy of Primary Central Nervous System Lymphoma in vitro and in vivo

References

• Soussain C, Choquet S, Blonski M, et al. Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: final analysis of the phase II ‘proof-of-concept’ iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network. Eur J Cancer. 2019;117:121–130. doi:10.1016/j.ejca.2019.05.02431279304
   PubMed Web of Science ®Google Scholar
• Korfel A, Schlegel U. Diagnosis and treatment of primary CNS lymphoma. Nat Rev Neurol. 2013;9(6):317. doi:10.1038/nrneurol.2013.8323670107
   PubMed Web of Science ®Google Scholar
• Citterio G, Calimeri T, Ajm F. Challenges and prospects in the diagnosis and treatment of primary central nervous system lymphoma. Expert Rev Neurother. 2018;18(5):1–15. doi:10.1080/14737175.2018.146270029027821
   PubMed Web of Science ®Google Scholar
• Braggio E, Van Wier S, Ojha J, et al. Genome-wide analysis uncovers novel recurrent alterations in primary central nervous system lymphomas. Clin Cancer Res. 2015;21(17):3986–3994. doi:10.1158/1078-0432.CCR-14-211625991819
   PubMed Web of Science ®Google Scholar
• Holdhoff M, Ambady P, Abdelaziz A, et al. High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma. Neurology. 2014;83(3):235. doi:10.1212/WNL.000000000000059324928128
   PubMed Web of Science ®Google Scholar
• Jara H. Primary central nervous system lymphoma: lessons and opportunities from 2 decades of CT and PET/CT. Radiology. 2019;292:191147.
   Web of Science ®Google Scholar
• Pentsova E, Deangelis LM, Omuro A. Methotrexate re-challenge for recurrent primary central nervous system lymphoma. J Neurooncol. 2014;117(1):161–165. doi:10.1007/s11060-014-1370-024481997
   PubMed Web of Science ®Google Scholar
• Pourtalebi JL, Mohammadi-Samani S, Heidari R, et al. In vitro- and in vivo evaluation of methotrexate-loaded hydrogel nanoparticles intended to treat primary CNS lymphoma via intranasal administration. J Pharm Pharm Sci. 2018;21(1):305–317. doi:10.18433/jpps2949630053381
   PubMedGoogle Scholar
• Abrey LE, Yahalom J, DeAngelis LM. Treatment for primary CNS lymphoma: the next step. J Clin Oncol. 2000;18:3144–3150. doi:10.1200/JCO.2000.18.17.314410963643
   PubMed Web of Science ®Google Scholar
• Batchelor TT. Primary central nervous system lymphoma: a curable disease. Hematol Oncol. 2019;15–18. doi:10.1002/hon.2598
   PubMed Web of Science ®Google Scholar
• Ferreri A, Cwynarski K, Pulczynski E, et al. Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial. Lancet Haematol. 2017;4(11):e510–e523. doi:10.1016/S2352-3026(17)30174-629054815
   PubMed Web of Science ®Google Scholar
• Fang C, Veiseh O, Kievit F, et al. Functionalization of iron oxide magnetic nanoparticles with targeting ligands: their physicochemical properties and in vivo behavior. Nanomedicine (Lond). 2010;5:1357–1369. doi:10.2217/nnm.10.5521128719
   PubMed Web of Science ®Google Scholar
• Kossatz S, Grandke J, Couleaud P, et al. Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery. Breast Cancer Res. 2015;17:66. doi:10.1186/s13058-015-0576-125968050
   PubMed Web of Science ®Google Scholar
• Shen B, Ma Y, Yu S, Ji. C. Smart multifunctional magnetic nanoparticle-based drug delivery system for cancer thermo-chemotherapy and intracellular imaging. ACS Appl Mater Interfaces. 2016;8(37):24502–245028. doi:10.1021/acsami.6b0977227573061
   PubMed Web of Science ®Google Scholar
• Glassell M, Robles J, Das R, et al. Exchange-coupled Fe3O4/CoFe2O4 nanoparticles for advanced magnetic hyperthermia. APS Meeting Abstracts, New Orleans, Louisiana; 2017.
   Google Scholar
• Kandasamy G, Sudame A, Luthra T, et al. Functionalized hydrophilic superparamagnetic iron oxide nanoparticles for magnetic fluid hyperthermia application in liver cancer treatment. ACS Omega. 2018;3:3991–4005. doi:10.1021/acsomega.8b0020730023884
   PubMed Web of Science ®Google Scholar
• Gresits I, Thuróczy G, Sági O, Gyüre-Garami B, Márkus BG, Simon F. Non-calorimetric determination of absorbed power during magnetic nanoparticle based hyperthermia. Sci Rep. 2018;8(1):12667. doi:10.1038/s41598-018-30981-x30140063
   PubMedGoogle Scholar
• Dadfar SM, Roemhild K, Drude NI, et al. Iron oxide nanoparticles: diagnostic, therapeutic and theranostic applications. Adv Drug Deliv Rev. 2019;138:302–325. doi:10.1016/j.addr.2019.01.00530639256
   PubMed Web of Science ®Google Scholar
• Hervault A, Thanh NTK. Magnetic nanoparticle-based therapeutic agents for thermo-chemotherapy treatment of cancer. Nanoscale. 2014;6:11553–11573. doi:10.1039/C4NR03482A25212238
   PubMed Web of Science ®Google Scholar
• Spirou SV, Costa Lima SA, Bouziotis P, et al. Recommendations for in vitro and in vivo testing of magnetic nanoparticle hyperthermia combined with radiation therapy. Nanomaterials (Basel). 2018;8. doi:10.3390/nano8050306
   Google Scholar
• Shen B, Ma Y, Yu S, et al. Smart multifunctional magnetic nanoparticle-based drug delivery system for cancer thermo-chemotherapy and intracellular imaging. ACS Appl Mater Interfaces. 2016;8:24502–24508. doi:10.1021/acsami.6b0977227573061
   PubMed Web of Science ®Google Scholar
• Barick KC, Singh S, Bahadur D, Lawande MA, Patkar DP, Hassan PA. Carboxyl decorated Fe3O4 nanoparticles for MRI diagnosis and localized hyperthermia. J Colloid Interface Sci. 2014;418:120–125. doi:10.1016/j.jcis.2013.11.07624461826
   PubMed Web of Science ®Google Scholar
• Liang P-C, Chen Y-C, Chiang C-F, et al. Doxorubicin-modified magnetic nanoparticles as a drug delivery system for magnetic resonance imaging-monitoring magnet-enhancing tumor chemotherapy. Int J Nanomedicine. 2016;11:2021–2037. doi:10.2147/IJN.S9413927274233
   PubMed Web of Science ®Google Scholar
• Hu Y, Meng L, Niu L, et al. Highly cross-linked and biocompatible polyphosphazene-coated superparamagnetic Fe3O4 nanoparticles for magnetic resonance imaging. Langmuir. 2013;29:9156–9163. doi:10.1021/la402119s23795597
   PubMed Web of Science ®Google Scholar
• Li Y, Liu J, Zhong Y, et al. Biocompatibility of Fe(3)O(4)@Au composite magnetic nanoparticles in vitro and in vivo. Int J Nanomedicine. 2011;6:2805–2819. doi:10.2147/IJN.S2459622131827
   PubMed Web of Science ®Google Scholar
• Vancsik T, Forika G, Balogh A, et al. Modulated electro-hyperthermia induced p53 driven apoptosis and cell cycle arrest additively support doxorubicin chemotherapy of colorectal cancer in vitro. Cancer Med. 2019. doi:10.1002/cam4.2330
   PubMed Web of Science ®Google Scholar
• Dulińska-Litewka J, Łazarczyk A, Hałubiec P, et al. Superparamagnetic iron oxide nanoparticles-current and prospective medical applications. Materials (Basel). 2019;12:undefined. doi:10.3390/ma12040617
   Web of Science ®Google Scholar
• Tay ZW, Chandrasekharan P, Chiu-Lam A, et al. Magnetic particle imaging-guided heating in vivo using gradient fields for arbitrary localization of magnetic hyperthermia therapy. ACS Nano. 2018;12:3699–3713. doi:10.1021/acsnano.8b0089329570277
   PubMed Web of Science ®Google Scholar
• Shakeri-Zadeh A, Khoei S, Khoee S, et al. Combination of ultrasound and newly synthesized magnetic nanocapsules affects the temperature profile of CT26 tumors in BALB/c mice. J Med Ultrason. 2015;42:9–16. doi:10.1007/s10396-014-0558-4
   PubMed Web of Science ®Google Scholar
• Cellai F, Munnia A, Viti J, et al. Magnetic hyperthermia and oxidative damage to DNA of human hepatocarcinoma cells. Int J Mol Sci. 2017;18:939. doi:10.3390/ijms18050939
   PubMed Web of Science ®Google Scholar
• Li W-S, Wang X-J, Zhang S, et al. Mild microwave activated, chemo-thermal combinational tumor therapy based on a targeted, thermal-sensitive and magnetic micelle. Biomaterials. 2017;131:36–46. doi:10.1016/j.biomaterials.2017.03.04828376364
   PubMed Web of Science ®Google Scholar
• Du Y, Liu X, Liang Q, et al. Optimization and design of magnetic ferrite nanoparticles with uniform tumor distribution for highly sensitive MRI/MPI performance and improved magnetic hyperthermia therapy. Nano Lett. 2019;19:3618–3626. doi:10.1021/acs.nanolett.9b0063031074627
   PubMed Web of Science ®Google Scholar
• Gao F, Xie W, Miao Y, et al. Magnetic hydrogel with optimally adaptive functions for breast cancer recurrence prevention. Adv Healthc Mater;2019 e1900203. doi:10.1002/adhm.20190020330985089
   PubMedGoogle Scholar
• Hadi F, Tavakkol S, Laurent S, et al. Combinatorial effects of radiofrequency hyperthermia and radiotherapy in the presence of magneto-plasmonic nanoparticles on MCF-7 breast cancer cells. J Cell Physiol. 2019. doi:10.1002/jcp.28599
   PubMed Web of Science ®Google Scholar
• Yan H, Shang W, Sun X, et al. Neoadjuvant nano-photothermal therapy used before operation effectively assists in surgery for breast cancer. Nanoscale. 2019;11:706–716. doi:10.1039/C8NR08109C30565621
   PubMedGoogle Scholar
• Lima SA, Gaspar A, Reis S, et al. Multifunctional nanospheres for co-delivery of methotrexate and mild hyperthermia to colon cancer cells. Mater Sci Eng C Mater Biol Appl. 2017;75:1420–1426. doi:10.1016/j.msec.2017.03.04928415433
   PubMedGoogle Scholar
• Asadi L, Shirvalilou S, Khoee S, et al. Cytotoxic effect of 5-Fluorouracil-loaded polymer-coated magnetite nanographene oxide combined with radiofrequency. Anticancer Agents Med Chem. 2018;18:1148–1155. doi:10.2174/187152061866618040415121829623854
   PubMed Web of Science ®Google Scholar
• Thirunavukkarasu GK, Cherukula K, Lee H, et al. Magnetic field-inducible drug-eluting nanoparticles for image-guided thermo-chemotherapy. Biomaterials. 2018;180:240–252. doi:10.1016/j.biomaterials.2018.07.02830055399
   PubMedGoogle Scholar
• Lorente C, Cabeza L, Clares B, et al. Formulation and in vitro evaluation of magnetoliposomes as a potential nanotool in colorectal cancer therapy. Colloids Surf B Biointerfaces. 2018;171:553–565. doi:10.1016/j.colsurfb.2018.07.07030096477
   PubMed Web of Science ®Google Scholar
• Carvalho SM, Leonel AG, Mansur AAP, et al. Bifunctional magnetopolymersomes of iron oxide nanoparticles and carboxymethylcellulose conjugated with doxorubicin for hyperthermo-chemotherapy of brain cancer cells. Biomater Sci. 2019;7:2102–2122. doi:10.1039/C8BM01528G30869664
   PubMed Web of Science ®Google Scholar
• Grauer O, Jaber M, Hess K, et al. Combined intracavitary thermotherapy with iron oxide nanoparticles and radiotherapy as local treatment modality in recurrent glioblastoma patients. J Neurooncol. 2019;141:83–94. doi:10.1007/s11060-018-03005-x30506500
   PubMed Web of Science ®Google Scholar
• Pinel S, Thomas N, Boura C, et al. Approaches to physical stimulation of metallic nanoparticles for glioblastoma treatment. Adv Drug Deliv Rev. 2019;138:344–357. doi:10.1016/j.addr.2018.10.01330414495
   PubMed Web of Science ®Google Scholar
• Tapeinos C, Marino A, Battaglini M, et al. Stimuli-responsive lipid-based magnetic nanovectors increase apoptosis in glioblastoma cells through synergic intracellular hyperthermia and chemotherapy. Nanoscale. 2018;11:72–88. doi:10.1039/C8NR05520C30357214
   PubMed Web of Science ®Google Scholar
• Montazerabadi A, Beik J, Irajirad R, et al. Folate-modified and curcumin-loaded dendritic magnetite nanocarriers for the targeted thermo-chemotherapy of cancer cells. Artif Cells Nanomed Biotechnol. 2019;47:330–340. doi:10.1080/21691401.2018.155767030688084
   PubMed Web of Science ®Google Scholar
• Lu Q, Dai X, Zhang P, et al. Fe3O4@Au composite magnetic nanoparticles modified with cetuximab for targeted magneto-photothermal therapy of glioma cells. Int J Nanomedicine. 2018;13:2491–2505. doi:10.2147/IJN.S15793529719396
   PubMed Web of Science ®Google Scholar
• Mantso T, Vasileiadis S, Lampri E, et al. Hyperthermia suppresses post-proliferation and tumor growth in murine malignant melanoma and colon carcinoma. Anticancer Res. 2019;39:2307–2315. doi:10.21873/anticanres.1334731092422
   PubMedGoogle Scholar
• Ge Y, Zhong Y, Ji G, et al. Preparation and characterization of Fe3O4@Au-C225 composite targeted nanoparticles for MRI of human glioma. PLoS One. 2018;13(4):e195703. doi:10.1371/journal.pone.0195703
   Web of Science ®Google Scholar
• Shakeri-Zadeh A, Shiran M-B, Khoee S, et al. A new magnetic nanocapsule containing 5-fluorouracil: in vivo drug release, anti-tumor, and pro-apoptotic effects on CT26 cells allograft model. J Biomater Appl. 2014;29:548–556. doi:10.1177/088532821453694024913615
   PubMed Web of Science ®Google Scholar
• Beik J, Khademi S, Attaran N, et al. A nanotechnology-based strategy to increase the efficiency of cancer diagnosis and therapy: folate-conjugated gold nanoparticles. Curr Med Chem. 2017;24:4399–4416. doi:10.2174/092986732466617081015491728799495
   PubMed Web of Science ®Google Scholar